Efficacy and safety of Omalizumab in the treatment of CSU: a meta-analysis of a randomized controlled trial
DermatologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Archives of dermatological research
- Publicado em
- 29 mai 2025
- Citações
- 4
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and safety of Omalizumab in the treatment of CSU: a meta-analysis of a randomized controlled trial
Wentao Zhang, Xue Cao, Lixia Liu
Descritores MeSH
- Omalizumab
- Chronic Urticaria
- Anti-Allergic Agents
- Quality of Life
- Severity of Illness Index
- Randomized Controlled Trials as Topic
- Treatment Outcome
- Humans
Veja também
Estudos relacionados
- Efficacy and Safety of Transcatheter Therapy for Patients With Tricuspid Regurgitation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Comparative efficacy and safety of biologics and systemic immunomodulatory treatments for chronic urticaria: Systematic review and network meta-analysis
- Omalizumab in pediatric chronic spontaneous urticaria: A systematic review and meta-analysis of efficacy and safety
- Combination of omalizumab with allergen immunotherapy versus immunotherapy alone for allergic diseases: A meta-analysis of randomized controlled trials